A three-site recognition cytosensor for accurate detection of circulating tumor cells based on novel branched Pt Au nanospheres and MnO2-GO-Au nanosheets
Linzhi Xie, Linxin He, Yang Fu, Yuxin Wei, Kun Zhang, Mei Chen
{"title":"A three-site recognition cytosensor for accurate detection of circulating tumor cells based on novel branched Pt Au nanospheres and MnO2-GO-Au nanosheets","authors":"Linzhi Xie, Linxin He, Yang Fu, Yuxin Wei, Kun Zhang, Mei Chen","doi":"10.1007/s00604-025-07032-0","DOIUrl":null,"url":null,"abstract":"<div><p> A novel electrochemical cytosensor was developed with a three-protein recognition strategy, employing branched Pt Au nanospheres (B-Pt-Au NPs) as tags and MnO<sub>2</sub>-GO-Au nanosheet-modified electrodes for circulating tumor cells (CTC) detection. This system integrates specific magnetic separation and CTC enrichment with sensitive electrochemical detection to identify rare A549 cells in whole blood. MnO<sub>2</sub>-GO-Au nanosheets, known for their high conductivity and biocompatibility, were used to modify a bare electrode, improving the electrochemical interface for biomolecules. The B-Pt-Au NPs could only approach the sensing interface and enhance the current signal through their specific electrocatalytic activity when all three specific proteins, i.e. mucin 1 (MUC1), epithelial cell adhesion molecule (EpCAM), and epidermal growth factor receptor (EGFR), of rare A549 cells in peripheral blood were simultaneously expressed on the cell membrane. The developed cytosensor demonstrated a detection limit as low as 1 cell mL⁻<sup>1</sup> and, more importantly, could accurately distinguish A549 cells from other cancer cells. Thus, this proposed strategy offers a powerful tool for liquid biopsy analysis of extremely rare CTCs in complex peripheral blood, with potential applications in reliable early diagnosis of non-small cell lung cancer (NSCLC).</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":705,"journal":{"name":"Microchimica Acta","volume":"192 3","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00604-025-07032-0.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microchimica Acta","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s00604-025-07032-0","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
A novel electrochemical cytosensor was developed with a three-protein recognition strategy, employing branched Pt Au nanospheres (B-Pt-Au NPs) as tags and MnO2-GO-Au nanosheet-modified electrodes for circulating tumor cells (CTC) detection. This system integrates specific magnetic separation and CTC enrichment with sensitive electrochemical detection to identify rare A549 cells in whole blood. MnO2-GO-Au nanosheets, known for their high conductivity and biocompatibility, were used to modify a bare electrode, improving the electrochemical interface for biomolecules. The B-Pt-Au NPs could only approach the sensing interface and enhance the current signal through their specific electrocatalytic activity when all three specific proteins, i.e. mucin 1 (MUC1), epithelial cell adhesion molecule (EpCAM), and epidermal growth factor receptor (EGFR), of rare A549 cells in peripheral blood were simultaneously expressed on the cell membrane. The developed cytosensor demonstrated a detection limit as low as 1 cell mL⁻1 and, more importantly, could accurately distinguish A549 cells from other cancer cells. Thus, this proposed strategy offers a powerful tool for liquid biopsy analysis of extremely rare CTCs in complex peripheral blood, with potential applications in reliable early diagnosis of non-small cell lung cancer (NSCLC).
期刊介绍:
As a peer-reviewed journal for analytical sciences and technologies on the micro- and nanoscale, Microchimica Acta has established itself as a premier forum for truly novel approaches in chemical and biochemical analysis. Coverage includes methods and devices that provide expedient solutions to the most contemporary demands in this area. Examples are point-of-care technologies, wearable (bio)sensors, in-vivo-monitoring, micro/nanomotors and materials based on synthetic biology as well as biomedical imaging and targeting.